Haemorrhages and Thromboembolic Venous Disease of the Postpartum

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20241 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-06

Study Completion Date

2021-04-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the frequencey and the determinants of postpartum major complications (hemorrhage and thrombosis) up to 3 months after delivery in the maternity hospitals of Finistère (Bretagne - France)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Detection of Bleeding Disorders Diagnosed After Vaginal Delivery Complicated by Severe Postpartum Hemorrhage

NCT06970860

Severe Postpartum Hemorrhage

NOT_YET_RECRUITING

Study of Biological Determinants of Bleeding Postpartum

NCT02884804

Postpartum Hemorrhage

COMPLETED

Secondary Postpartum Hemorrhage

NCT03840889

Postpartum Hemorrhage Maternal Morbidity Retained Placenta +2 more

UNKNOWN

Study on Retroplacental Hematomas in Finistère

NCT04168606

Placental Abruption Placenta Diseases

COMPLETED

Venous Thromboembolism in Pregnancy Study

NCT00856076

Venous Thromboembolism Intrauterine Fetal Death

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is an analytical observational prospective multicenter cohort study , conducted on all the maternity hospitals in Finistère (Bretagne - France), with a biological collection.

This protocol allows to study all women at risk of PPH (Postpartum Hemorrhage) and postpartum venous thromboembolic disease, including maternity level 1-3 without case selection. The prospective nature of the study should provide a more detailed analysis of exposures in this particular population of women (risk factors related to the field, childbirth, the postpartum events ...).

The events of interest were PPH and venous thromboembolic disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postpartum Hemorrhage Venous Thromboembolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any woman giving birth and supported in one of Gynaecology Obstetrics services of a maternity Finistere.
* Women ≥ 16 at the time of the collection of non-opposition.
* For minor patients: understanding the patient and at least one parent.
* All births ≥ 15 weeks gestation.